SOCRA Basic 1 — Questions and Answers
Question 1: What is 21CFR50 Subpart D?
- Records and Reports
- Protection of Human Subjects
- IRB Functions and Operations
- Additional Safeguards for Children in Clinical Investigations (Correct answer)
Correct answer: Additional Safeguards for Children in Clinical Investigations
21 CFR Part 50 Subpart D specifically addresses 'Additional Safeguards for Children in Clinical Investigations.' This subpart outlines the specific requirements and protections that must be in place when children are involved as subjects in clinical research. It ensures that children, as a vulnerable population, are adequately protected and that their participation is ethically justified.
Question 2: What is a person or an organization (commercial, academic, or other) contracted by the sponsor of a clinical trial to perform one or more trial-related duty and function?
- CRO - Center for Research Operations
- CRO - Clinical Research Organization
- CRO - Contracted Research Organization (Correct answer)
- CRO - Contracted Research Operations
Correct answer: CRO - Contracted Research Organization
A CRO, or Contracted Research Organization, is an entity hired by a sponsor to manage and perform various tasks related to a clinical trial. These tasks can include study design, monitoring, data management, and regulatory affairs. The term 'Contracted Research Organization' accurately reflects its role as an external, specialized service provider for clinical research.
Question 3: What is 21CFR50.54 Subpart D?
- Clinical investigations involving greater than minimal risk but presenting the prospect of direct benefit to individual subjects.
- Requirements for permission by parents or guardians and for assent by children.
- Clinical investigations not otherwise approvable that present an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children. (Correct answer)
- Clinical investigations involving greater than minimal risk and no prospect of direct benefit to individual subjects, but likely to yield generalizable knowledge about the subjects' disorder or condition.
Correct answer: Clinical investigations not otherwise approvable that present an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children.
21 CFR 50.54, which falls under Subpart D, details the conditions for approving clinical investigations that are 'not otherwise approvable' but present a significant opportunity. Specifically, it allows for studies involving children that pose greater than minimal risk and no prospect of direct benefit, provided they offer a clear path to understanding, preventing, or alleviating a serious problem affecting children's health or welfare. This section ensures that crucial research for children can proceed under strict ethical guidelines.
Question 4: The Code of Federal Regulations that applies to Electronic Records; Electronic Signatures is..
- 21CFR11 (Correct answer)
- 21CFR812
- 21CFR312
- 21CFR56
Correct answer: 21CFR11
21 CFR Part 11 is the Code of Federal Regulations that governs electronic records and electronic signatures for FDA-regulated industries. It establishes the criteria under which electronic records and signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. Compliance with 21 CFR Part 11 is essential for maintaining data integrity and regulatory compliance in clinical research.
Question 5: What is 21CFR50.25 Subpart B?
- Elements of Informed Consent (Correct answer)
- Documentation of Informed Consent
- Exemptions of Informed Consent
- Documentation of Emergency Use of Experimental Treatments
Correct answer: Elements of Informed Consent
21 CFR 50.25, found within Subpart B, precisely outlines the 'Elements of Informed Consent' that must be provided to prospective research subjects. This section details the essential information, such as the study's purpose, risks, benefits, and alternatives, that must be communicated to ensure a subject can make an informed decision about participation. It serves as a cornerstone for ethical human subjects research.
Question 6: The Code of Federal Regulations that applies to Investigational New Drug Applications is..
- 21CFR312 (Correct answer)
- 45CFR46
- 21CFR11
- 21CFR812
Correct answer: 21CFR312
21 CFR Part 312 specifically governs 'Investigational New Drug Applications' (INDs). This regulation outlines the requirements for submitting an IND to the FDA, which is necessary before a new drug can be tested in human subjects. It details the information sponsors must provide regarding the drug's manufacturing, preclinical testing, and proposed clinical protocols to ensure subject safety.
Question 7: The international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects is known as...
- The ICH
- Fundamental Ethical Principles (FEP)
- The Declaration of Helsinki
- Good Clinical Practice (GCP) (Correct answer)
Correct answer: Good Clinical Practice (GCP)
Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve human subjects. Adherence to GCP ensures the protection of the rights, safety, and well-being of trial subjects, and that the clinical trial data are credible and accurate. It is a globally recognized benchmark for ethical research.
Question 8: What is the FDA form 3455?
- Disclosure - Financial Interests and Agreements of Clinical Investigators (Correct answer)
- Certification - Financial Interests and Arrangements of Clinical Investigators
- Declaration of Conflict of Interest
- Certification - Disclosure of Conflict of Interest
Correct answer: Disclosure - Financial Interests and Agreements of Clinical Investigators
FDA Form 3455 is specifically titled 'Disclosure - Financial Interests and Agreements of Clinical Investigators.' This form is used by clinical investigators to disclose any financial interests or arrangements they or their immediate family members have with the sponsor of a covered clinical study. This disclosure is crucial for identifying and managing potential conflicts of interest that could bias study results.
Question 9: What does 21CFR54 deal with?
- IRB regulations
- Exemptions of Informed Consent for emergency use
- Financial disclosure of clinical investigators (Correct answer)
- Protection of human subjects: prisoners
Correct answer: Financial disclosure of clinical investigators
21 CFR Part 54 deals with 'Financial Disclosure by Clinical Investigators.' This regulation requires sponsors to collect and report information about financial interests of clinical investigators that could affect the reliability of study data. Its purpose is to ensure the integrity of clinical trial results by identifying and mitigating potential biases arising from financial relationships.
Question 10: What is 45CFR46?
- HHS - Protection of Research Participants
- FDA - Protection of Research Participants
- DDS - Protection of Human Subjects
- HHS - Protection of Human Subjects (Correct answer)
Correct answer: HHS - Protection of Human Subjects
45 CFR Part 46 is the Department of Health and Human Services (HHS) regulation titled 'Protection of Human Subjects.' This is often referred to as the 'Common Rule' and provides the foundational ethical framework for federally funded research involving human subjects. It outlines requirements for Institutional Review Boards (IRBs), informed consent, and protections for vulnerable populations.
Question 11: The World Medical Association (WMA) ethical principals for medical research involving human subjects is called....
- The National Research Act
- The Bellmont Report
- The Declaration of Helsinki (Correct answer)
- The International Research Act
Correct answer: The Declaration of Helsinki
The Declaration of Helsinki is a set of ethical principles for medical research involving human subjects, developed by the World Medical Association (WMA). First adopted in 1964, it is widely regarded as the cornerstone document on human research ethics. It emphasizes the well-being of the research subject over the interests of science and society.
SOCRA Basic 1
What is 21CFR50 Subpart D?